Montironi R, Lopez-Beltran A, Scarpelli M, Mazzucchelli R, Cheng L
School of Medicine, Polytechnic University of the Marche Region, United Hospitals, Ancona, Italy.
Histopathology. 2008 Dec;53(6):621-33. doi: 10.1111/j.1365-2559.2008.03025.x. Epub 2008 Apr 18.
The morphological classification used in this essay has been based on the most recent World Health Organization (WHO) classification of tumours of the urinary system (i.e. 2004 WHO classification). It includes epithelial abnormalities and metaplasias as well as dysplasias and carcinomas in situ. The lesions are broadly subdivided into two major groups: benign, preneoplastic and non-invasive neoplastic lesions of the urothelium; and benign, preneoplastic and non-invasive neoplastic bladder lesions other than urothelial. Each of these lesions is defined with strict morphological criteria to provide more accurate information to urologists and oncologists in managing patients. There is still debate in the literature as to whether the 2004 WHO system should be the only one to be used and whether the 1973 WHO system should be abandoned.
本文所采用的形态学分类基于世界卫生组织(WHO)最新的泌尿系统肿瘤分类(即2004年WHO分类)。它包括上皮异常、化生以及发育异常和原位癌。这些病变大致分为两大类:尿路上皮的良性、癌前和非侵袭性肿瘤性病变;以及除尿路上皮外的良性、癌前和非侵袭性肿瘤性膀胱病变。对每一种病变都用严格的形态学标准进行定义,以便在患者管理方面为泌尿科医生和肿瘤学家提供更准确的信息。关于2004年WHO系统是否应成为唯一使用的系统以及1973年WHO系统是否应被摒弃,文献中仍存在争议。